Loading clinical trials...
Loading clinical trials...
MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b: a Multicenter, Placebo-controlled, Double-blind Randomized Trial
Conditions
Interventions
Combination of Lopinavir /Ritonavir and Interferon beta-1b
Placebo
Locations
2
Saudi Arabia
Intensive Care Unit, King Abdulaziz Medical City, National Guard Health Affairs
Riyadh, Saudi Arabia
King Abdullah International Medical Research Center
Riyadh, Saudi Arabia
Start Date
July 1, 2016
Primary Completion Date
May 1, 2020
Completion Date
May 1, 2020
Last Updated
May 20, 2020
Lead Sponsor
King Abdullah International Medical Research Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions